Judicial Watch Sues for Records on COVID Vaccine Safety Studies - Judicial Watch
(Washington, DC) – Judicial Watch announced today it filed a Freedom of Information Act (FOIA) lawsuit against the U.S. Department of Health and Human Services (HHS) for records on COVID-19 vaccine safety studies (Judicial Watch, Inc. v. U.S. Department of Health and Human Services (No. 1:22-cv-03153)).The lawsuit was filed in the U.S. District Court for the District of Columbia after National Institutes of Allergies and Infectious Diseases (a component of HHS) inadequately responded to a June 1, 2022, Judicial Watch FOIA request for:
NEW FDA Documents on Vaccine Safety Revealed! - Judicial Watch
Judicial Watch received 466 pages of records from the Department of Health and Human Services (HHS) regarding biodistribution studies and related data for the COVID-19 vaccines that show a key component of the vaccines developed by Pfizer/BioNTech, lipid nanoparticles (LNPs), were found outside the injection site, mainly the liver, adrenal glands, spleen and ovaries of test animals, eight to 48 hours after injection.
Did Pfizer Fail to Perform industry Standard Animal Testing Prior to Initiation of mRNA Clinical Trials?
TrialSite has learned of material information regarding mRNA vaccine safety revealed by a freedom of information act (FOIA) request filed by a group of Canadian physicians. These doctors have become concerned about COVID-19 mRNA vaccine safety. This new safety information involves the Pfizer mRNA-based vaccine known as BNT162b2 or “Comirnaty.” The FOIA documents reveal animal study results demonstrating that the Pfizer mRNA-based vaccine does not remain at the injection site, but rather appears to spread widely after injection. According to the documents, pre-clinical studies show that the active part of the vaccine (mRNA-lipid nanoparticles), which produce the spike protein, spreads throughout the body and is then concentrated in various organs, including the ovaries and spleen. The FOIA-produced data sets are incomplete, so the full meaning of these data cannot be determined at this time. TrialSite has also learned via regulatory documents that apparently (at least in their European Medicines Agency submission), Pfizer did not follow industry-standard quality management practices during preclinical toxicology studies during vaccines, as key studies did not meet good laboratory practice (GLP). The full panel of industry-standard reproductive toxicity and genotoxicity studies were apparently also not performed. But does this matter in light of the risk-benefit analysis associated with regulatory emergency use authorization (EUA)?
Pharmaceutical Expert Says FDA Colluding with Pfizer and Moderna, Not Addressing Alarming Data
Alexandra Latypova ("Sasha") is a retired pharmaceutical industry executive and entrepreneur. She holds an MBA degree from Dartmouth College and spent approximately 25 years in pharmaceutical research
The Pfizer Inoculations For COVID-19 – More Harm Than Good – PDF
The Pfizer 6 month data shows that Pfizer's COVID-19 inoculations cause more illness than they prevent. Plus, an overview of the Pfizer trial flaws in both design and execution.